User talk:Medview

From Wikipedia, the free encyclopedia

Dear Medview: Neither phosphatidylcholine (PC) nor deoxycholate (DC) have been approved by the FDA as active ingredients in any drug. Deoxycholate was listed as an inactive component of a no-longer-marketed antifungal agent (i.e., FUNGIZONE), though that drug is no longer available commercially in the US. Furthermore, the approval of deoxycholate as an inactive ingredient in FUNGIZONE was for the INTRAVENOUS administration of that drug at far lower doses than those administered by medspas. Injecting a drug into the blood is very different than injecting a drug into somebody’s fat pad.

Phosphatidylcholine has no FDA approval of ANY SORT, either as an active or an inactive ingredient.

Also, PCDC is not currently the subject of an open IND (Investigational New Drug) application with the FDA, so it is misleading to suggest that PCDC is being tested in FDA-sanctioned clinical trials. It is not. So don’t say it.

Because your statements lack the benefit of factual accuracy, I am removing them. Please contact me if you wish to discuss or dispute the accuracy of my proposed changes.

Regards, N David